XML 18 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities    
Net income (loss) $ 6,513 $ (7,145)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 12,144 8,370
Deferred income taxes 374 (1,380)
Loss from discontinued operations 816 186
Restructuring charges 394 992
Impairment recoveries (2,384)  
Gains on dispositions of property and other assets (50) (150)
Share-based compensation expense 1,999 1,066
Excess tax benefit from share-based compensation arrangements   (28)
Other non-cash items, net 1,287 937
Change in operating assets and liabilities (excluding the impact of acquisitions):    
Receivables (26,219) (6,942)
Inventories (4,333) (9,807)
Accounts payable 29,437 21,366
Restructuring liabilities (1,137) (1,314)
Accrued compensation (16,027) (7,147)
Customer deposits 17,755 26,684
Income taxes payable (3,206) (2,080)
Other assets and liabilities, net 14,875 (6,569)
Net cash provided by operating activities 32,238 17,039
Cash flows from investing activities    
Capital expenditures (14,662) (7,323)
Proceeds from insurance 4,583  
Cash paid for acquired businesses, net (1,661) (57,766)
Proceeds from dispositions of property and other assets 550 229
Net cash used in investing activities (11,190) (64,860)
Cash flows from financing activities    
Proceeds from borrowings 17,574 50,000
Payments on debt and capital lease obligations (30,985) (15,029)
Dividends paid on common stock (2,038) (2,024)
Debt issuance costs   (339)
Common stock purchased for treasury (1,204) (651)
Excess tax benefit from share-based compensation arrangements   28
Net cash (used in) provided by financing activities (16,653) 31,985
Effect of exchange rate changes on cash and cash equivalents 139 640
Net change in cash and cash equivalents 4,534 (15,196)
Cash and cash equivalents, beginning of year 20,900 56,531
Cash and cash equivalents, end of period $ 25,434 $ 41,335